Bone Biologics Corporation
BBLG
$0.55
-$0.01-1.07%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 4.03M | 4.53M | 5.33M | 6.05M | 6.64M |
| Total Receivables | 7.00K | 7.80K | 9.90K | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 136.30K | 180.50K | 242.90K | 81.40K | 152.80K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 261.60K | 260.90K | 209.00K | 220.30K | 209.00K |
| Total Current Assets | 4.44M | 4.98M | 5.80M | 6.35M | 7.00M |
|
|
|||||
| Total Current Assets | 4.44M | 4.98M | 5.80M | 6.35M | 7.00M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 4.44M | 4.98M | 5.80M | 6.35M | 7.00M |
|
|
|||||
| Total Accounts Payable | 511.50K | 308.90K | 417.90K | 333.10K | 403.70K |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 500.00 | 400.00 | 700.00 | 1.20K | 2.40K |
| Total Other Current Liabilities | 500.00 | 400.00 | 700.00 | 1.20K | 2.40K |
| Total Current Liabilities | 512.00K | 309.40K | 418.60K | 334.30K | 406.10K |
|
|
|||||
| Total Current Liabilities | 512.00K | 309.40K | 418.60K | 334.30K | 406.10K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 512.00K | 309.40K | 418.60K | 334.30K | 406.10K |
|
|
|||||
| Common Stock & APIC | 93.59M | 93.57M | 93.51M | 93.46M | 93.38M |
| Retained Earnings | -89.67M | -88.90M | -88.13M | -87.45M | -86.78M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 3.92M | 4.67M | 5.38M | 6.02M | 6.60M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 3.92M | 4.67M | 5.38M | 6.02M | 6.60M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 3.92M | 4.67M | 5.38M | 6.02M | 6.60M |
|
|
|||||